Does ATEZOLIZUMAB Cause Pulmonary embolism? 284 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 284 reports of Pulmonary embolism have been filed in association with ATEZOLIZUMAB (Tecentriq Hybreza). This represents 0.8% of all adverse event reports for ATEZOLIZUMAB.
284
Reports of Pulmonary embolism with ATEZOLIZUMAB
0.8%
of all ATEZOLIZUMAB reports
78
Deaths
174
Hospitalizations
How Dangerous Is Pulmonary embolism From ATEZOLIZUMAB?
Of the 284 reports, 78 (27.5%) resulted in death, 174 (61.3%) required hospitalization, and 24 (8.5%) were considered life-threatening.
Is Pulmonary embolism Listed in the Official Label?
Yes, Pulmonary embolism is listed as a known adverse reaction in the official FDA drug label for ATEZOLIZUMAB.
What Other Side Effects Does ATEZOLIZUMAB Cause?
Death (3,591)
Off label use (2,340)
Disease progression (1,828)
Pyrexia (1,599)
Diarrhoea (1,490)
Fatigue (1,253)
Anaemia (1,195)
Pneumonia (1,036)
Nausea (953)
Dyspnoea (938)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which ATEZOLIZUMAB Alternatives Have Lower Pulmonary embolism Risk?
ATEZOLIZUMAB vs ATLANTIC SALMON OIL
ATEZOLIZUMAB vs ATOGEPANT
ATEZOLIZUMAB vs ATOMOXETINE
ATEZOLIZUMAB vs ATOMOXETINE\ATOMOXETINE
ATEZOLIZUMAB vs ATORVASTATIN